Skip to main content
David Yang, MD, Pathology, Madison, WI

DavidTYangMD

Pathology Madison, WI

Hematopathology, Anatomic Pathology, Clinical Pathology

Professor, University of Wisconsin

Dr. Yang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yang's full profile

Already have an account?

  • Office

    600 Highland Ave
    Madison, WI 53792
    Phone+1 608-263-8443
    Fax+1 608-262-7174

Education & Training

  • University of Utah Health
    University of Utah HealthFellowship, Hematopathology, 2005 - 2006
  • University of Utah Health
    University of Utah HealthResidency, Pathology-Anatomic and Clinical, 2005
  • Medical University of South Carolina
    Medical University of South CarolinaResidency, Internal Medicine, 1994 - 1997
  • Loma Linda University School of Medicine
    Loma Linda University School of MedicineClass of 1994

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1997 - 2025
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Journal Articles

  • Unique Dependence on Sos1 in KrasG12D-Induced Leukemogenesis  
    David Yang, Erik A Ranheim, Blood
  • Downregulating Notch Counteracts KrasG12D-Induced ERK Activation and Oxidative Phosphorylation in Myeloproliferative Neoplasm  
    Erik A Ranheim, David Yang, Warren S Pear, Lan Zhou, Mignon Loh, Eric Padron, Elliot Stieglitz, Nature

Press Mentions

  • Banking on Patient Samples to Advance COVID-19 Research
    Banking on Patient Samples to Advance COVID-19 ResearchNovember 20th, 2020
  • Researchers Identify Mechanism Controlling Red Blood Cell Development
    Researchers Identify Mechanism Controlling Red Blood Cell DevelopmentOctober 7th, 2016
  • Society of Hematopathology Quarterly Case Winter 2016: Primary Myelofibrosis with an Unusual MPL Mutation: Integrating Molecular Testing into the Diagnosis and Prognosis of BCR-ABL1 Negative Myeloproliferative Neoplasms. WMSH1601
    Society of Hematopathology Quarterly Case Winter 2016: Primary Myelofibrosis with an Unusual MPL Mutation: Integrating Molecular Testing into the Diagnosis and Prognosis of BCR-ABL1 Negative Myeloproliferative Neoplasms. WMSH1601March 3rd, 2016